BioSig Technologies to Partner with High Lantern Group

Santa Monica, CA, April 26, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has appointed High Lantern Group (HLG) to assist in building a global stakeholder engagement strategy as the […]

ams Introduces Sensor Reference Design for Blood Pressure, Vital Signs for Smart Health and Wearables

PREMSTAETTEN, Austria–(BUSINESS WIRE)–ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, today announced the release of the first integrated vital sign sensor reference design based on its AS7024. The solution can perform accurate, fast and convenient 24/7 cuffless blood pressure measurement. The new vital signs sensor reference […]

The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025

LONDON, April 23, 2018 /PRNewswire/ — Microelectronic Medical Implants Market Analysis Report by Product (Pacemakers & Defibrillators, Neurostimulators, Implantable Drug Pumps, Spinal Fusion Stimulators), by Technology, And Segment Forecasts, 2018 – 2025 Download the full report: https://www.reportbuyer.com/product/5360535 The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025, according to […]

VGS Initiates U.S. Pivotal Trial to Evaluate the Use of Its VEST Technology for Bypass Surgery

TEL AVIV, Israel, April 23, 2018 /PRNewswire/ — Vascular Graft Solutions Ltd (VGS) announces on enrollment of the first 20 patients into the VEST US pivotal trial that will evaluate the safety and effectiveness of the VEST, a novel external support device for treatment of saphenous vein graft disease after coronary artery […]

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

BROOMFIELD, Colo.–(BUSINESS WIRE)–ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc. (NYSE:MDT), a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA’s proposed […]

Tinton Falls Company Gets FDA Approval For Early Heart Attack Detection Device

Angel Medical Systems, Inc. of Tinton Falls announced that they have received FDA pre-market approval on a medical device that detects heart attacks before patients experience symptoms. The AngelMed Guardian System is an implantable heart monitor with internal and external alerting capabilities to urge at-risk patients with pre-existing cardiac conditions […]

Aziyo Announces CanGaroo Strategic Co-Distribution Agreement with BIOTRONIK US

SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced that it has entered into a US co-distribution agreement for its CanGaroo® Bio Envelope with BIOTRONIK, Inc., a global leader in cardio- and endovascular medical technology. CanGaroo Bio Envelopes are a natural extracellular matrix (ECM) scaffold that […]

APN Health Announces Commercial Release of its Innovative Cardiac Mapping System

MILWAUKEE–(BUSINESS WIRE)–APN Health, LLC (www.apnhealth.com) announces its Navik 3D mapping system is commercially released and in clinical use. The first clinical case using the technology was performed on March 22nd at St. Luke’s Medical center in Milwaukee. Navik 3D is intended for catheter-based atrial and ventricular mapping using compatible catheters […]

Bardy Diagnostics™ Recognized by MedTech Outlook as One of the Top 10 Cardio Vascular Device Companies of 2018

SEATTLE, April 19, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it has been recognized as one of the Top 10 Cardio Vascular Device Companies of 2018 by MedTech Outlook Magazine, an industry periodical committed to covering the […]

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

VANCOUVER, April 17, 2018 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced completion of enrollment for the Phase 4 SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the Company’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), in the post-authorization […]